TotalMarketCap

Lexeo Therapeutics

LXEONasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$239.575 M

$2.92 -9.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Lexeo Therapeutics (LXEO) has a market capitalization of $239.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$100.0M

Loss-making

Shares outstanding

82,046,255

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #89SAB BiotherapeuticsSABS$266.6M
  2. #90Lineage Cell TherapeuticsLCTX$247.3M
  3. #91Lexeo TherapeuticsLXEO$239.6M
  4. #92Fate TherapeuticsFATE$225.9M
  5. #93Cabaletta BioCABA$214.5M

What if Lexeo Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$344,157.98

Per share 117,862× higher

Bitcoin $1.53T

$18,621.79

Per share 6,377× higher

Apple $5.02T

$61,133.60

Per share 20,936× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Lexeo Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.